Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems

Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so forth. Owing to their unique size dependent properties and ability to incorporate drugs, SLNs present an opportunity to bu...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 10; no. 4; p. 191
Main Authors Mishra, Vijay, Bansal, Kuldeep K, Verma, Asit, Yadav, Nishika, Thakur, Sourav, Sudhakar, Kalvatala, Rosenholm, Jessica M
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 18.10.2018
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so forth. Owing to their unique size dependent properties and ability to incorporate drugs, SLNs present an opportunity to build up new therapeutic prototypes for drug delivery and targeting. SLNs hold great potential for attaining the goal of targeted and controlled drug delivery, which currently draws the interest of researchers worldwide. The present review sheds light on different aspects of SLNs including fabrication and characterization techniques, formulation variables, routes of administration, surface modifications, toxicity, and biomedical applications.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics10040191